Fabio
5.2 KiB
5.2 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11. | Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11. | us/states/tn | Tennessee General Assembly | 114 | HB 1984 | Tennessee HB 1984 (114) |
|
|
enacted |
|
1 | 31 | 5 | 2026-01-22 | 2026-04-24 | openstates | ocd-bill/e3159374-8a60-4419-b6e6-ebfb3f672914 | https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB1984&ga=114 | 296be32cf85c989fdf276ee11c0b47d94c1d7ed925ba84aabd9bb5ddd171f563 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Tennessee HB 1984 (114) — Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Current Version (committee substitute) — source
Votes
- FLOOR VOTE: Third Consideration 3/30/2026 Passed (1) — 28–3 (pass) · upper
- FLOOR VOTE: CONSENT CALENDAR PASSAGE ON THIRD CONSIDERATION 3/30/2026 Passed (1) — 82–1 (pass) · lower
- HOUSE HEALTH SUBCOMMITTEE: Rec. for pass by s/c ref. to Health Committee 2/18/2026 Passed (4) — 6–0 (pass) · lower
- HOUSE CALENDAR & RULES COMMITTEE: H. Placed on Consent Calendar 3/26/2026 (2) — 0–0 (fail) · lower
- HOUSE HEALTH COMMITTEE: Rec. for pass; ref to Calendar & Rules Committee 3/17/2026 Passed (3) — 20–0 (pass) · lower
Sponsors
- Hill — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2026-01-22 Filed for introduction
filing - 2026-02-02 Intro., P1C.
introduction - 2026-02-04 Assigned to s/c Health Subcommittee
referral-committee - 2026-02-04 P2C, ref. to Health Committee
referral-committee - 2026-02-11 Placed on s/c cal Health Subcommittee for 2/18/2026
- 2026-02-11 Sponsor(s) withdrawn.
sponsorship - 2026-02-11 Sponsor change.
sponsorship - 2026-02-12 Sponsor(s) Added.
sponsorship - 2026-02-18 Rec. for pass by s/c ref. to Health Committee
committee-passage-favorable - 2026-02-25 Placed on cal. Health Committee for 3/3/2026
- 2026-02-25 Sponsor(s) Added.
sponsorship - 2026-03-03 Action def. in Health Committee to 3/10/2026
- 2026-03-04 Placed on cal. Health Committee for 3/10/2026
- 2026-03-10 No Action Taken
- 2026-03-11 Placed on cal. Health Committee for 3/17/2026
- 2026-03-17 Rec. for pass; ref to Calendar & Rules Committee
committee-passage-favorable - 2026-03-25 Placed on cal. Calendar & Rules Committee for 3/26/2026
- 2026-03-26 H. Placed on Consent Calendar for 3/30/2026
- 2026-03-30 Passed Senate, Ayes 28, Nays 3
passage - 2026-03-30 Senate substituted House Bill for companion Senate Bill.
substitution - 2026-03-30 Received from House, Passed on First Consideration
introduction - 2026-03-30 Sponsor(s) Added.
sponsorship - 2026-03-30 Engrossed; ready for transmission to Sen.
receipt - 2026-03-30 Passed H., Ayes 82, Nays 1, PNV 10
passage - 2026-04-01 Enrolled; ready for sig. of H. Speaker.
enrolled - 2026-04-06 Signed by Senate Speaker
passage - 2026-04-06 Signed by H. Speaker
passage - 2026-04-07 Transmitted to Governor for his action.
executive-receipt - 2026-04-16 Signed by Governor.
executive-signature - 2026-04-24 Effective date(s) 04/16/2026
- 2026-04-24 Pub. Ch. 753
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/e3159374-8a60-4419-b6e6-ebfb3f672914. Confidence: reported (aggregated from official Tennessee legislature records).